Abstract
Langerhans cell histiocytosis (LCH) is a myeloid neoplasm of dendritic cells (DC), characterized by the clonal expansion of myeloid precursors that express the surface antigens CD1a+ and CD207+. LCH is a rare and infrequent disease, of predominantly pediatric onset with an annual incidence ranging between 2 and 9 cases per million, being even rarer in adults, with an estimated annual incidence of approximately 1 case per million, although this value probably reduced is due to an underdiagnosed disease in this population. The clinical course is heterogeneous, it can present from an indolent self-limited lesion (solitary eosinophilic granuloma) to a disseminated disease with rapidly progressive organ dysfunction, which can lead to death. The Histiocyte Society (HS) classifies the clinical forms of LCH according to the number and type of organs affected: single system LCH (SSLCH) if one organ/system is affected (either unifocal or multifocal) and multisystem LCH (MS- LCH) if two or more organ systems are involved. We will present two cases of HCL, one with involvement of a SS and another MS.
References
Allen CE, Merad M, McClain KL. Langerhans-Cell Histiocytosis. N Engl J Med. 2018 Aug 30;379(9):856- 868.
Georgakopoulou D, Anastasilakis AD, Makras P. Adult Langerhans Cell Histiocytosis and the Skeleton. J Clin Med. 2022 Feb 9;11(4):909.
Goyal G, Tazi A, Go RS, Rech KL, Picarsic JL, Vassallo R, Young JR, Cox CW, Van Laar J, Hermiston ML, Cao XX, Makras P, Kaltsas G, Haroche J, Collin M, McClain KL, Diamond EL, Girschikofsky M. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood. 2022 Apr 28;139(17):2601-2621.
Rodriguez-Galindo C, Allen CE. Langerhans cell histiocytosis. Blood. 2020 Apr 16;135(16):1319-1331.
Cantu MA, Lupo PJ, Bilgi M, Hicks MJ, Allen CE, McClain KL. Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. PLoS One. 2012;7(8):e43257.
Aricò M, Girschikofsky M, Généreau T, Klersy C, Mc- Clain K, Grois N, Emile JF, Lukina E, De Juli E, Danesino C. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer. 2003 Nov;39(16):2341-8.
Makras P, Alexandraki KI, Chrousos GP, Grossman AB, Kaltsas GA. Endocrine manifestations in Langerhans cell histiocytosis. Trends Endocrinol Metab. 2007 Aug;18(6):252-7.
Yeh EA, Greenberg J, Abla O, Longoni G, Diamond E, Hermiston M, Tran B, Rodriguez-Galindo C, Allen CE, McClain KL; North American Consortium for Histiocytosis. Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas. Pediatr Blood Cancer. 2018 Jan;65(1).
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar
